Collegium Pharmaceutical (COLL) Enterprise Value (2015 - 2026)

Collegium Pharmaceutical has reported Enterprise Value for 12 years, with the latest figure at $1.0 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 44.51% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 44.51% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 46.53% from the prior year.
• Enterprise Value was $1.0 billion for Q2 2026 at Collegium Pharmaceutical, up from $649.9 million in the prior quarter.
• The five-year high for Enterprise Value was $1.1 billion in Q3 2024, with the low at $407.0 million in Q3 2022.
• Average Enterprise Value over 5 years is $711.3 million, with a median of $690.6 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 159.09% in 2024, then retreated 27.15% in 2025.
• Over 5 years, Enterprise Value stood at $611.6 million in 2022, then climbed by 9.61% to $670.4 million in 2023, then grew by 10.09% to $738.0 million in 2024, then jumped by 46.53% to $1.1 billion in 2025, then retreated by 5.02% to $1.0 billion in 2026.
• The last three Enterprise Value figures came in at $1.0 billion (Q2 2026), $649.9 million (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.